Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma

Proteasome inhibition is an effective treatment for multiple myeloma (MM); however, targeting different components of the ubiquitin–proteasome system (UPS) remains elusive. Our RNA-interference studies identified proteasome-associated ubiquitin-receptor Rpn13 as a mediator of MM cell growth and surv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia
Main Authors: Song, Yan, Park, Paul M. C., Wu, Lei, Ray, Arghya, Picaud, Sarah, Li, Deyao, Wimalasena, Virangika K., Du, Ting, Filippakopoulos, Panagis, Anderson, Kenneth C., Qi, Jun, Chauhan, Dharminder
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6783320/
https://ncbi.nlm.nih.gov/pubmed/30962579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-019-0467-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados